Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

World journal of gastroenterology - 14 May 2016

Wang An-Qiang, Zheng Yong-Chang, Du Juan, Zhu Cheng-Pei, Huang Han-Chun, Wang Shan-Shan, Wu Liang-Cai, Wan Xue-Shuai, Zhang Hao-Hai, Miao Ruo-Yu, Sang Xin-Ting, Zhao Hai-Tao

Abstract excerpt

Combined hepatocellular cholangiocarcinoma (CHC) accounts for 0.4%-14.2% of primary liver cancer cases and possesses pathological features of both hepatocellular carcinoma and cholangiocarcinoma. Since this disease was first described and classified in 1949, the classification of CHC has continuously evolved. The latest definition and classification of CHC by the World Health Organization is based on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bile Duct Neoplasms
Share to Bile Ducts, Intrahepatic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Hepatocellular

Share to Cell Differentiation

Share to Cell Lineage

Share to Cholangiocarcinoma

Share to Liver Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 27182157
DOI: 10.3748/wjg.v22.i18.4459
PMCID: PMC4858629

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.PMID 27182157Read ↗

Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.Semantic proximity Read ↗

Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center StudySemantic proximity Read ↗

Pathogenesis of CholangiocarcinomaSemantic proximity Read ↗

Composite liver tumors: a radiologic-pathologic correlation.Semantic proximity Read ↗

Recent Advances in Pathology of Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

Cholangiocarcinoma--controversies and challenges.Semantic proximity Read ↗

Recent Advances in Understanding CholangiocarcinomaSemantic proximity Read ↗

Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.Semantic proximity Read ↗

Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.Semantic proximity Read ↗

Establishment of two novel organoid lines from patients with combined hepatocellular cholangiocarcinomaSemantic proximity Read ↗

Oncogenic driver genes and tumor microenvironment determine the type of liver cancerSemantic proximity Read ↗

Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.